Detalles de la búsqueda
1.
The moderating roles of self-efficacy and depression in dual-task walking in multiple sclerosis: A test of self-awareness theory.
J Int Neuropsychol Soc
; 29(3): 274-282, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35465869
2.
The association between MRI brain volumes and computerized cognitive scores of people with multiple sclerosis.
Brain Cogn
; 145: 105614, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32927305
3.
The impact of subjective cognitive fatigue and depression on cognitive function in patients with multiple sclerosis.
Mult Scler
; 24(2): 196-204, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28273778
4.
Multiple Sclerosis, Fatigue, Expanded Disability Status Scale: A Cross-Sectional Exploration of Sleep Efficiency and Quantitative Sleep Parameters.
Int J MS Care
; 26(2): 57-60, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38482517
5.
Peering further into the mind's eye: combining visual evoked potential and optical coherence tomography measures enhances insight into the variance in cognitive functioning in multiple sclerosis.
J Neurol
; 271(2): 658-673, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38091086
6.
De-escalation of Disease-Modifying Therapy for People with Multiple Sclerosis Due to Safety Considerations: Characterizing 1-Year Outcomes in 25 People Who Switched from Ocrelizumab to Diroximel Fumarate.
Adv Ther
; 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38861218
7.
Exploring the relationship between manual dexterity and cognition in people with multiple sclerosis: 9-hole peg and multiple cognitive functions.
Mult Scler Relat Disord
; 88: 105696, 2024 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38850796
8.
Humoral immune response after Ad26.COV2.S vaccination in patients with multiple sclerosis treated with natalizumab.
Mult Scler J Exp Transl Clin
; 9(4): 20552173231218117, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38089563
9.
Cognitive impairment in people with multiple sclerosis: Perception vs. performance - factors that drive perception of impairment differ for patients and clinicians.
Mult Scler Relat Disord
; 69: 104410, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36399966
10.
Multiple sclerosis and quality of life: The role of cognitive impairment on quality of life in people with multiple sclerosis.
Mult Scler Relat Disord
; 79: 104966, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37690436
11.
Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS?
Mult Scler Relat Disord
; 73: 104630, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36965219
12.
Variability of objective gait measures across the expanded disability status scale in people living with multiple sclerosis: A cross-sectional retrospective analysis.
Mult Scler Relat Disord
; 59: 103645, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35124304
13.
Measuring cognitive function by the SDMT across functional domains: Useful but not sufficient.
Mult Scler Relat Disord
; 60: 103704, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35259683
14.
The relationship between cognitive impairment, cognitive fatigue, and visual evoked potential latency in people with multiple sclerosis.
Mult Scler Relat Disord
; 57: 103349, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158458
15.
Longitudinal assessment of the relationship between visual evoked potentials and cognitive performance in multiple sclerosis.
Clin Neurophysiol
; 137: 66-74, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35279530
16.
Individual differences in visual evoked potential latency are associated with variance in brain tissue volume in people with multiple sclerosis: An analysis of brain function-structure correlates.
Mult Scler Relat Disord
; 68: 104116, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36041331
17.
Prolonged visual evoked potential latency predicts longitudinal worsening of fatigue in people with multiple sclerosis.
Mult Scler Relat Disord
; 67: 104073, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35964554
18.
Visual evoked potential latency predicts cognitive function in people with multiple sclerosis.
J Neurol
; 268(11): 4311-4320, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33870445
19.
Validity of a multi-domain computerized cognitive assessment battery for patients with multiple sclerosis.
Mult Scler Relat Disord
; 30: 154-162, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30772674
20.
Correction to: Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis.
CNS Drugs
; 32(12): 1183, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30244406